Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1971-9-29
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0031-4005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
318-22
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4327111-Blood,
pubmed-meshheading:4327111-Cerebrospinal Fluid,
pubmed-meshheading:4327111-Cytomegalovirus,
pubmed-meshheading:4327111-Cytomegalovirus Infections,
pubmed-meshheading:4327111-Floxuridine,
pubmed-meshheading:4327111-Humans,
pubmed-meshheading:4327111-Infant, Newborn,
pubmed-meshheading:4327111-Male,
pubmed-meshheading:4327111-Saliva,
pubmed-meshheading:4327111-Urine
|
pubmed:year |
1971
|
pubmed:articleTitle |
Floxuridine treatment of congenital cytomegalic inclusion disease.
|
pubmed:publicationType |
Journal Article
|